Return to study ST001232 main page

MB Sample ID: SA087927

Local Sample ID:Blank-30012018
Subject ID:SU001300
Subject Type:Cultured cells
Subject Species:Plasmodium falciparum
Taxonomy ID:5833
Genotype Strain:3D7
Cell Strain Details:MR4-3D7
Subject Comments:All were MACS seperated Trophozoite infected red blood cells
Cell Counts:1x10^8 per technical replicate

Select appropriate tab below to view additional metadata details:


Subject:

Subject ID:SU001300
Subject Type:Cultured cells
Subject Species:Plasmodium falciparum
Taxonomy ID:5833
Genotype Strain:3D7
Cell Strain Details:MR4-3D7
Subject Comments:All were MACS seperated Trophozoite infected red blood cells
Cell Counts:1x10^8 per technical replicate

Factors:

Local Sample IDMB Sample IDFactor Level IDLevel ValueFactor Name
Blank-30012018SA087927FL012939No treatmentDrug treatment

Collection:

Collection ID:CO001294
Collection Summary:Aspiration of 4 mL media, transfer of sample (1 mL) to 1.5 mL tubes
Sample Type:Cultured cells
Collection Method:Aspiration of 4 mL media, transfer of sample (1 mL) to 1.5 mL tubes
Collection Location:Biological safety hood
Collection Frequency:once after 2.5 hours treatment
Collection Duration:Collection and extraction occurs in under 20 minutes per plate
Volumeoramount Collected:1 mL containing 1x10^8 infected cells
Storage Conditions:On ice
Collection Vials:1.5 mL eppendorf
Storage Vials:1.5 mL eppendorf
Tissue Cell Quantity Taken:1 mL containing 1x10^8 infected cells

Treatment:

Treatment ID:TR001315
Treatment Summary:Infected Red Blood cells were exposed to Antimalarial Compounds, associated with sample names. No treatment (as in the case of blanks) denotes these samples did not undergo the treatment incubation (blanks are made at the point of extraction in this case), whereas treated with no drug relates that these samples (no drug or ND) underwent the same treatment incubation as other treated samples, but in this case as a negative control with no drug administered.
Treatment:Abiotic
Treatment Compound:Atovaquone, Dihydroartemisinin (DHA), Ferroquin (FQ), GNF-Pf-5660, KAI407, Lumefantrine (LMF), Methylene Blue, MMV00017 (Naphthoquine), MMV000442, MMV00787, MMV007181, MMV019555, MMV020746, MMV021735, MMV022224, MMV022478, MMV027496, MMV030666, MMV085071, MMV665794, MMV665939, MMV667491, MMV668311, MMV675939, Mefloquine (MQ), Piperaquine (PPQ), WLL
Treatment Route:Addition to media
Treatment Dose:10xIC50
Treatment Dosevolume:Always less than 10 uL per 5 mL sample
Treatment Doseduration:2.5 hours
Treatment Vehicle:Stocks kept in either DMSO or Water
Cell Storage:Temperature/Gas Mixture controlled incubator
Cell Growth Container:6-well plate
Cell Growth Config:5 mL per well, each with 1x10^8 cells
Cell Media:RPMI 1640 w/ Albumax, Gentamycin, Hypoxanthine, HEPES, Sodium Bicarbonate
Cell Harvesting:PBS Wash followed by 90% methanol extraction

Sample Preparation:

Sampleprep ID:SP001308
Sampleprep Summary:Samples washed in PBS, spun down, aspirated, extracted in 90% methanol with labelled aspartate, then dried, resuspended in water labelled with chlorpropamide
Sampleprep Protocol Filename:Metabolite_Extraction_for_LCMS_2017_Llinas.pdf
Processing Method:Wash, Lysis, Drying, resuspension
Processing Storage Conditions:On ice
Extraction Method:90% Methanol Lysis
Extract Cleanup:Centrifugation, pellet removal
Extract Storage:-80℃
Sample Resuspension:100 uL water with chlorpropamide
Sample Spiking:Labelled Aspartate, Chlorpropamide

Combined analysis:

Analysis ID AN002050
Analysis type MS
Chromatography type Reversed phase
Chromatography system Thermo Dionex Ultimate 3000
Column Waters XSelect HSS T3 XP (100 x 2.1mm,2.5um)
MS Type ESI
MS instrument type Orbitrap
MS instrument name Thermo Exactive Plus Orbitrap
Ion Mode NEGATIVE
Units peak area

Chromatography:

Chromatography ID:CH001489
Instrument Name:Thermo Dionex Ultimate 3000
Column Name:Waters XSelect HSS T3 XP (100 x 2.1mm,2.5um)
Chromatography Type:Reversed phase

MS:

MS ID:MS001902
Analysis ID:AN002050
Instrument Name:Thermo Exactive Plus Orbitrap
Instrument Type:Orbitrap
MS Type:ESI
MS Comments:Blank subtraction, RSD cutoffs both by RSD per sample and pooled QCs to eliminate metabolites affected by time-dependency
Ion Mode:NEGATIVE
  logo